We all know about Alzheimer’s Disease, in fact, many of us know someone who has been impacted by it. But there is another ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

Monash University researchers are assessing a new drug that could be a game changer for the dementia that has struck US actor Bruce Willis, and ...

Managing dementia in the complex landscape of neurological disorders stands out as a formidable challenge, affecting millions ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

Lewy Body Dementia is progressive, and causes uncontrollable tremors, problems with memory, attention, and sleep.

Tau proteins help to stabilise the internal skeleton of nerve cells (neurons) in the brain. But in Alzheimer’s disease, these ...

In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Now, for the first time, a new group of drugs called monoclonal antibodies have been shown to slow down the decline in thinking and memory in Alzheimer’s patients, the most common form of dementia.